Impact of COVID-19 on Medication Adherence in Dyslipidemia Patients
Author Information
Author(s): Jang Jieun, Oh Hyun Jung, Lee Eui-Kyung
Primary Institution: School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, Republic of Korea
Hypothesis
How did the COVID-19 pandemic affect medication adherence and persistence in patients with dyslipidemia?
Conclusion
Medication adherence and persistence improved in both new and existing patients with dyslipidemia despite the COVID-19 pandemic.
Supporting Evidence
- PDC significantly increased post-COVID-19, with existing PWD showing a larger increase by 4.74 units.
- Both groups exhibited lower risks of medication discontinuation post-COVID-19.
- New PWD had fewer annual visits, whereas existing PWD had more visits.
Takeaway
Even though there was a pandemic, people taking medicine for cholesterol did a better job of sticking to their medications.
Methodology
The study used nationwide claims data to analyze medication adherence and persistence among patients with dyslipidemia before and after the COVID-19 pandemic.
Limitations
The study could not determine the impact of COVID-19 on medication adherence based on the duration of illness.
Participant Demographics
Adult patients (aged ≥18 years) diagnosed with dyslipidemia.
Statistical Information
P-Value
p < 0.0001
Confidence Interval
[0.774–0.786]
Statistical Significance
p < 0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website